18383638|t|Fluoroquinolones: psychiatric adverse effects.
18383638|a|(1) In France, between 1985 and 2002, there were 590 reports of psychiatric adverse effects in patients receiving fluoroquinolones. These mainly included cases of confusion, hallucinations, agitation, delirium, insomnia and drowsiness. Elderly patients appear to be at greatest risk. (2) The reports implicated all available fluoroquinolones and, in most cases, oral intake. (3) Fluoroquinolone dose regimens should be reduced in cases of renal failure. The Cockcroft formula is used to derive creatinine clearance from plasma creatinine levels.
18383638	0	16	Fluoroquinolones	Chemical	MESH:D024841
18383638	18	45	psychiatric adverse effects	Disease	MESH:D001523
18383638	111	138	psychiatric adverse effects	Disease	MESH:D001523
18383638	142	150	patients	Species	9606
18383638	161	177	fluoroquinolones	Chemical	MESH:D024841
18383638	221	235	hallucinations	Disease	MESH:D006212
18383638	237	246	agitation	Disease	MESH:D011595
18383638	248	256	delirium	Disease	MESH:D003693
18383638	258	266	insomnia	Disease	MESH:D007319
18383638	291	299	patients	Species	9606
18383638	372	388	fluoroquinolones	Chemical	MESH:D024841
18383638	426	441	Fluoroquinolone	Chemical	MESH:D024841
18383638	486	499	renal failure	Disease	MESH:D051437
18383638	541	551	creatinine	Chemical	MESH:D003404
18383638	574	584	creatinine	Chemical	MESH:D003404
18383638	Positive_Correlation	MESH:D024841	MESH:D003693
18383638	Association	MESH:D003404	MESH:D024841
18383638	Association	MESH:D024841	MESH:D051437
18383638	Positive_Correlation	MESH:D024841	MESH:D001523
18383638	Positive_Correlation	MESH:D024841	MESH:D011595
18383638	Positive_Correlation	MESH:D024841	MESH:D006212
18383638	Positive_Correlation	MESH:D024841	MESH:D007319

